Review finds oral phenylephrine ineffective, leading to a proposal for market removal. The U.S. Food and Drug Administration (FDA) recently proposed removing oral phenylephrine from over-the-counter (OTC) products…
Read MorePrescription Drugs
FDA Approves New Hemophilia Treatment Hympavzi
Novel therapy targets blood-clotting proteins to prevent bleeding episodes. The U.S. Food and Drug Administration (FDA) has approved Hympavzi (marstacimab) as a novel treatment for hemophilia. The drug…
Read MoreHurricane Helene Recovery Efforts Continue, States of Emergency Extended
Tens of thousands are still without power in North Carolina and Georgia. In Georgia, the Department of Health and Human Services is putting prescription replacement programs in place…
Read MoreSupreme Court Declines Appeal by Former Pharma Executive
The court upholds the $64 million penalty, holding the former CEO liable for price gouging and fraud. The Supreme Court declined to hear an appeal filed by former…
Read MoreHHS Adds 54 Drugs to Medicaid Drug Rebate Program
Drugs will have a lowered coinsurance rate for 822,000 enrollees. The Department of Health and Human Services (HHS) announced that 54 drugs have been added to Medicaid’s Drug…
Read MoreMedicare Announces Maximum Drug Prices After Negotiations
HHS secretary states that the negotiations will save Americans $3.7 billion in the first year. Medicare announced its first finalized list of drug price maximums for 10 prescription…
Read MoreHHS Reports Lower Medicare Prices on 10 Drugs
The deal is expected to save billions for Medicare and reduce out-of-pocket costs for millions of seniors starting in 2026. The Department of Health and Human Services (HHS)…
Read MoreHHS Updates Payment Policies for Medicare and Medicaid
Issues final rule for inpatient hospitals and long-term care hospitals. The Department of Health and Human Services (HHS) issued a final rule last week updating Medicare payment policies…
Read MoreHHS Issues Final Guidance for Medicare Prescription Payment Plan
New initiative to ease out-of-pocket drug costs and cap annual expenses at $2,000 for Medicare beneficiaries by 2025. The Department of Health and Human Services (HHS), through the…
Read MoreLegislators Raise Concerns About Inflated Rx Costs for Troops
Some members of Congress question the prescription monopoly under Pentagon’s Tricare. Bipartisan members of Congress have questioned the Pentagon about the exclusive prescription contract the Defense Health Agency…
Read More